Critical Innovations is currently developing multiple medical devices toward regulatory clearance. The company focuses on task-shifting evidence-based interventions to earlier echelons of care and more general specialty levels, to simplify management and allow for rapid provision in emergency and combat environments. To date, the company has worked under more than 50 different Department of Defense awards from all military branches charged with medical technology development (i.e. U.S. Army, Air Force, Navy, and Space Force), including such agencies as the Air Force Medical Support Agency; Army Medical Research and Development Command; Defense Health Agency; and, Office of Naval Research. Additional agencies include Defense Advanced Research Projects Agency (DARPA). Contract types have included Small Business Innovation Research (SBIR), Joint Warfighter, Congressionally Directed Medical Research Programs, and Other Transactional Authority. As a prime contractor, Critical Innovations has a 99.5% rate of on-time program deliverable achievement. For Phase II awards, the company has 100% transition rate to Phase III funding. As a fully turnkey company, Critical Innovations possesses all the necessary capabilities and experience to guide a product seamlessly from proof-of-concept through to manufacturing, regulatory clearance, and commercialization.